Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

GermanyBack to Germany

Clinical trials in Frankfurt (oder)

8 clinical trials in Frankfurt (oder), Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Frankfurt (oder) at a glance
8
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

8 trials in Frankfurt (oder)

Open in trial search

Study Comparing Odronextamab with Rituximab and Chemotherapy for Patients with Untreated Follicular Lymphoma

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Regeneron Pharmaceuticals Inc.

Double hit lymphoma+7

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:Universitaet Des Saarlandes

Plasma cell myeloma

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Universitaetsklinikum Heidelberg AöR

Prodromal Alzheimer's disease

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Florbetaben (18F)
  • Sponsor:F. Hoffmann-La Roche AG

Diffuse large B-cell lymphoma+1

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Regeneron Pharmaceuticals Inc.

Follicular lymphoma+2

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Lenalidomide
  • Sponsor:Regeneron Pharmaceuticals Inc.

Chronic lymphocytic leukaemia

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Chlorambucil
  • Sponsor:F. Hoffmann-La Roche AG

Acute myeloid leukaemia+1

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:GWT-Tud GmbH

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Frankfurt (oder)

What the registry says about research in the country

01 Frankfurt (oder)
Hemic and Lymphatic Diseases
Clinical research in Frankfurt (oder) is strongly focused on blood cancers, with studies covering follicular lymphoma, marginal zone lymphoma, chronic lymphocytic leukemia, and multiple myeloma. These trials are mainly testing new treatment combinations and comparing them with current standard care to improve response and disease control. New approaches for follicular lymphoma and related indolent lymphomas Treatment studies in relapsed or refractory lymphoma and B-cell non-Hodgkin’s lymphoma Therapy comparisons for chronic lymphocytic leukemia in patients with other health conditions Trials in multiple myeloma and other hematologic cancers The overall goal is to find safer and more effective options for patients with complex hematologic malignancies, especially where long-term disease control is a priority.
Neoplasms
Another major area of trial activity is cancer research in broader tumor types, including diffuse large B-cell lymphoma and other aggressive lymphomas. These studies are evaluating whether newer targeted or combined therapies can improve outcomes for older adults and people who may not tolerate intensive treatment well. Studies for diffuse large B-cell lymphoma and other aggressive B-cell lymphomas Research in older or less fit patients needing gentler treatment options Comparisons of new immunotherapy-based regimens with standard chemotherapy Trials designed to improve remission rates and disease-free survival This reflects a practical effort to refine treatment choices in oncology, with attention to both effectiveness and tolerability.
Nervous System Diseases
Clinical trials in nervous system disease are centered on Alzheimer’s disease, exploring whether an investigational therapy can be safe and well tolerated while also influencing disease-related brain changes. The research aims to support earlier intervention and improve understanding of how treatment may affect the course of memory and cognitive decline. Studies in Alzheimer’s disease at risk and early symptom stages Research on safety and tolerability of a potential new therapy Evaluation of effects on brain amyloid accumulation Work aimed at better treatment strategies for neurodegenerative disease These trials contribute to efforts in neurology to slow progression and improve future care for people affected by cognitive disorders.
Mixed Hematologic and Oncology Research
Several studies in the city also bridge multiple areas of hematology and oncology, including treatment strategies for patients preparing for allogeneic stem cell transplantation. These trials are looking at whether alternative regimens can better control disease before transplant and improve outcomes afterward. Research in higher-risk MDS and oligoblastic AML Treatment planning before allogeneic blood cell transplantation Studies comparing disease control strategies ahead of transplant Focus on improving progression-free and event-free survival The research supports more tailored treatment pathways for patients with challenging blood disorders and advanced cancer-related conditions.
Back to GermanyAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.